ONCT
Oncternal Therapeutics, Inc. Common Stock
ONCT
ONCT
Delisted
ONCT was delisted on the 2nd of December, 2024.
58 hedge funds and large institutions have $9.31M invested in Oncternal Therapeutics, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
58
Holders Change
-3
Holders Change %
-4.92%
% of All Funds
0.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
12
Reduced
13
Closed
10
Calls
$28K
Puts
$1K
Net Calls
+$27K
Net Calls Change
-$38K
Top Buyers
Top Sellers
1 |
Renaissance Technologies
New York
|
$242K |
2 |
Two Sigma Investments
New York
|
$175K |
3 |
E
Ergoteles
New York
|
$12.4K |
4 |
Two Sigma Advisers
New York
|
$215K |
5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
$0 |